ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,566Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 761

$449K Total Retail Price of All Prescriptions

Rank: 167 out of 761

704 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 441 373 1 4
SIMVASTATIN 343 308 2 2
LEVOTHYROXINE SODIUM 337 287 3 3
HYDROCODONE-ACETAMINOPHEN 328 258 S3 4 5
LISINOPRIL 304 277 5 1
AMLODIPINE BESYLATE 274 240 6 6
FUROSEMIDE 260 228 7 7
METOPROLOL TARTRATE 237 223 8 14
GABAPENTIN 228 188 9 15
LOSARTAN POTASSIUM 211 191 10 13
WARFARIN SODIUM 197 192 11 9
ZOLPIDEM TARTRATE 164 136 12 22
METFORMIN HCL 154 138 13 10
CITALOPRAM HBR 153 144 14 19
TRIAMTERENE-HCTZ 151 139 15 42
HYDROCHLOROTHIAZIDE 145 134 16 11
OXYCODONE HCL 145 63 S2 16 24
POTASSIUM CHLORIDE 143 131 18 18
LOVASTATIN 138 114 19 17
METOPROLOL SUCCINATE 125 117 20 16
ATENOLOL 119 110 21 8
DONEPEZIL HCL 116 113 22 33
DIOVAN 102 102 23 58
GLIMEPIRIDE 101 101 24 48
CLOPIDOGREL 95 85 25 66
SERTRALINE HCL 93 83 26 25
SPIRIVA 87 69 27 56
ATORVASTATIN CALCIUM 87 85 27 12
TAMSULOSIN HCL 83 75 29 27
FLUTICASONE PROPIONATE 75 72 30 29
NAPROXEN 67 43 31 105
CEFUROXIME 67 55 31 299
DIGOXIN 66 66 33 43
PLAVIX 65 60 34 119
FENTANYL 65 57 S2 34 57
CIPROFLOXACIN HCL 63 54 36 63
ISOSORBIDE MONONITRATE ER 62 46 37 72
PROAIR HFA 61 51 38 32
FLUOXETINE HCL 61 61 38 31
OXYBUTYNIN CHLORIDE ER 61 61 38 137
PREDNISONE 60 53 41 30
BENAZEPRIL HCL 60 56 41 112
NEXIUM 57 42 43 98
CARVEDILOL 56 42 44 26
TRAMADOL HCL 56 47 44 34
ALLOPURINOL 55 54 46 28
ENALAPRIL MALEATE 55 55 46 71
ZETIA 54 49 48 87
OXYCODONE-ACETAMINOPHEN 52 50 S2 49 49
PREMARIN 50 50 R 50 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.